Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORD18 (also called U18) is a non-coding RNA of the C/D box family, characterized by highly conserved C (UGAUGA) and D (CUGA) box sequence motifs[2][5]. It is located within the nucleolus, where it acts as a guide RNA to direct site-specific 2’-O-methylation of ribosomal RNA (rRNA) and some small nuclear RNAs (snRNAs) during the maturation of these RNAs, a process fundamental for the assembly and function of ribosomes in all eukaryotic cells[1][2][3][5]. Human SNORD18 is present in several closely related copies (SNORD18A, SNORD18B, SNORD18C), typically found in introns of genes encoding ribosomal proteins[2]. SNORD18 is essential for the correct chemical modification of rRNA, but there is no evidence that it functions as a direct therapeutic target, nor does it have a recognized role in human disease by itself[2][4][6]. Key points: - **Small nucleolar RNA SNORD18** is a non-coding RNA, *not* a protein, receptor, enzyme, or pharmacological target. - It guides **site-specific methylation** of rRNA for ribosome function[1][2][3][5]. - Not considered a drug target and not causally associated with any human disease[2][5][6]. - No known role as a **biomarker** or safety concern. This molecule is a housekeeping RNA essential for fundamental cellular processes, but it has no direct relevance as a therapeutic drug target.
Not applicable. There are no drugs known to act via this RNA, and its function is not druggable in a conventional sense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORD18 (SNORD18).